Propulsid Suits Dismissed As Case Draws To A Close

Law360, New York (July 25, 2007, 12:00 AM EDT) -- The massive multidistrict litigation against drug maker Johnson & Johnson and its subsidiary Janssen Pharmaceutica over heartburn drug Propulsid is wrapping up as thousands of plaintiffs become eligible for a cut of the $105 million settlement.

Consensual motions to dismiss several hundred cases have been filed in the U.S. District Court for the Eastern District of Louisiana this week, marking the last chapter in the long-running product liability case.

Almost 30,000 Propulsid users agreed to dismiss their cases against the pharmaceutical companies after opting for inclusion...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.